Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,351
Closed -$387K 21
2025
Q1
$387K Sell
2,351
-26,456
-92% -$4.4M 0.34% 21
2024
Q4
$4.69M Sell
28,807
-571
-2% -$102K 3.89% 11
2024
Q3
$5.74M Buy
29,378
+6
+0% +$1.11K 4.34% 12
2024
Q2
$5.09M Buy
29,372
+7,955
+37% +$1.32M 3.93% 10
2024
Q1
$3.62M Buy
21,417
+5,000
+30% +$937K 2.73% 18
2023
Q4
$3.24M Sell
16,417
-1,900
-10% -$336K 2.55% 18
2023
Q3
$3.19M Sell
18,317
-8,809
-32% -$1.6M 2.69% 17
2023
Q2
$4.67M Sell
27,126
-959
-3% -$166K 3.57% 13
2023
Q1
$4.67M Sell
28,085
-28,569
-50% -$4.68M 3.73% 11
2022
Q4
$8.3M Sell
56,654
-844
-1% -$125K 6.66% 4
2022
Q3
$8.53M Sell
57,498
-1,102
-2% -$184K 7.34% 2
2022
Q2
$10.1M Sell
58,600
-2,259
-4% -$391K 8.02% 2
2022
Q1
$12M Buy
60,859
+9,340
+18% +$1.85M 8.38% 2
2021
Q4
$10.1M Buy
51,519
+23,402
+83% +$5.13M 8.59% 3
2021
Q3
$5.46M Buy
+28,117
New +$5.67M 4.15% 9

Other funds holding ZTS

XXEC Inc's ZTS Position: Q2 2025 in Review

XXEC Inc sold out of Zoetis (ZTS) in Q2 2025, closing a stake of 2,351 shares — an estimated $387K sold.

XXEC Inc first reported a position in ZTS in Q3 2021 and held it in 15 quarters. The position peaked at $12M in Q1 2022. 1,871 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • XXEC Inc reported no remaining Zoetis position as of Q2 2025 after selling out during the quarter.
  • XXEC Inc sold 2,351 Zoetis shares in Q2 2025, an estimated $387K.
  • XXEC Inc first reported a position in Zoetis in Q3 2021 and held it in 15 quarters.
  • XXEC Inc's Zoetis position peaked at $12M in Q1 2022.
  • 1,871 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on XXEC Inc's 13F filing for Q2 2025, filed 13 Aug 2025.